DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 205786
Email this page to a colleague
NDA 205786 describes ISENTRESS, which is a drug marketed by Merck Sharp Dohme and is included in three NDAs. It is available from seven suppliers. There are six patents protecting this drug and one Paragraph IV challenge. Additional details are available on the ISENTRESS profile page.
The generic ingredient in ISENTRESS is raltegravir potassium. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.
The generic ingredient in ISENTRESS is raltegravir potassium. There are five drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the raltegravir potassium profile page.
Summary for 205786
| Tradename: | ISENTRESS |
| Applicant: | Merck Sharp Dohme |
| Ingredient: | raltegravir potassium |
| Patents: | 4 |
| Formulation / Manufacturing: | see details |
DrugPatentWatch® Estimated Generic Entry Opportunity Date for 205786
Generic Entry Date for 205786*:
Constraining patent/regulatory exclusivity:
Dosage:
POWDER;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 205786
| Mechanism of Action | HIV Integrase Inhibitors |
Medical Subject Heading (MeSH) Categories for 205786
Suppliers and Packaging for NDA: 205786
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| ISENTRESS | raltegravir potassium | POWDER;ORAL | 205786 | NDA | Merck Sharp & Dohme Corp. | 0006-3603 | 0006-3603-60 | 60 PACKET in 1 CARTON (0006-3603-60) > 1 GRANULE, FOR SUSPENSION in 1 PACKET (0006-3603-01) |
| ISENTRESS | raltegravir potassium | POWDER;ORAL | 205786 | NDA | Merck Sharp & Dohme Corp. | 0006-3603 | 0006-3603-61 | 60 PACKET in 1 CARTON (0006-3603-61) > 1 GRANULE, FOR SUSPENSION in 1 PACKET (0006-3603-01) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | POWDER;ORAL | Strength | EQ 100MG BASE/PACKET | ||||
| Approval Date: | Dec 20, 2013 | TE: | RLD: | Yes | |||||
| Regulatory Exclusivity Expiration: | May 22, 2021 | ||||||||
| Regulatory Exclusivity Use: | PEDIATRIC EXCLUSIVITY | ||||||||
| Patent: | ⤷ Free Forever Trial | Patent Expiration: | Apr 3, 2024 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
| Patent: | ⤷ Free Forever Trial | Patent Expiration: | Apr 21, 2023 | Product Flag? | Substance Flag? | Delist Request? | Y | ||
Complete Access Available with Subscription
